BrainStorm
John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs
John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs
Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.
This episode is sponsored by Genentech and Eisai.
About This Episode
Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.